These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8379450)

  • 1. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances.
    Radin NS; Shayman JA; Inokuchi J
    Adv Lipid Res; 1993; 26():183-213. PubMed ID: 8379450
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts.
    Uemura K; Sugiyama E; Tamai C; Hara A; Taketomi T; Radin NS
    J Biochem; 1990 Oct; 108(4):525-30. PubMed ID: 2149853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death.
    Hisaki H; Shimasaki H; Ueta N; Kubota M; Nakane M; Nakagomi T; Tamura A; Masuda H
    Brain Res; 2004 Aug; 1018(1):73-7. PubMed ID: 15262207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides.
    Li R; Ladisch S
    Cancer Res; 1996 Oct; 56(20):4602-5. PubMed ID: 8840970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
    di Bartolomeo S; Spinedi A
    Biochem Biophys Res Commun; 2001 Oct; 288(1):269-74. PubMed ID: 11594784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase.
    Radin NS
    Mol Chem Neuropathol; 1994; 21(2-3):111-27. PubMed ID: 8086032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of glucosylceramide synthase.
    Shayman JA; Lee L; Abe A; Shu L
    Methods Enzymol; 2000; 311():373-87. PubMed ID: 10563341
    [No Abstract]   [Full Text] [Related]  

  • 8. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase.
    Nicholson KM; Quinn DM; Kellett GL; Warr JR
    Br J Cancer; 1999 Oct; 81(3):423-30. PubMed ID: 10507766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes.
    Takami Y; Abe A; Matsuda T; Shayman JA; Radin NS; Walter RJ
    J Dermatol; 1998 Feb; 25(2):73-7. PubMed ID: 9563272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of [(3)H]thymidine transport is a nonspecific effect of PDMP in primary cultures of mouse epidermal keratinocytes.
    Griner RD; Bollag WB
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1219-24. PubMed ID: 10945880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentation and topology of glucosylceramide synthesis.
    Cantatore JL; Murphy SM; Lynch DV
    Biochem Soc Trans; 2000 Dec; 28(6):748-50. PubMed ID: 11171193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel PDMP analogues.
    Hillaert U; Boldin-Adamsky S; Rozenski J; Busson R; Futerman AH; Van Calenbergh S
    Bioorg Med Chem; 2006 Aug; 14(15):5273-84. PubMed ID: 16621573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis: data on the evolution of the signaling system.
    Kovács P; Pintér M; Csaba G
    Cell Biochem Funct; 2000 Dec; 18(4):269-80. PubMed ID: 11180290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulators of glycosphingolipid biosynthesis (PDMP): application to cell biology].
    Inokuchi J
    Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2495-502. PubMed ID: 9883678
    [No Abstract]   [Full Text] [Related]  

  • 15. L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats.
    Inokuchi J; Kuroda Y; Kosaka S; Fujiwara M
    Acta Biochim Pol; 1998; 45(2):479-92. PubMed ID: 9821877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sulfobutyl ether beta-cyclodextrin as a vehicle for D-threo-1-phenyl-2-decanoylamino-3-morpholinopropanol-relat ed glucosylceramide synthase inhibitors.
    Abe A; Gregory S; Lee L; Shayman JA
    Anal Biochem; 2000 Dec; 287(2):344-7. PubMed ID: 11112286
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucosylceramide synthesis is required for basic fibroblast growth factor and laminin to stimulate axonal growth.
    Boldin S; Futerman AH
    J Neurochem; 1997 Feb; 68(2):882-5. PubMed ID: 9003082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells.
    Rosenwald AG; Pagano RE
    J Lipid Res; 1994 Jul; 35(7):1232-40. PubMed ID: 7964184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.
    Manning LS; Radin NS
    Br J Cancer; 1999 Nov; 81(6):952-8. PubMed ID: 10576650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
    Wennekes T; van den Berg RJ; Donker W; van der Marel GA; Strijland A; Aerts JM; Overkleeft HS
    J Org Chem; 2007 Feb; 72(4):1088-97. PubMed ID: 17243712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.